Skip to main content

MoneyWorks4Me

Eris Lifesciences informs about board meeting

19 Nov 2025 Evaluate
Eris Lifesciences has informed that the meeting of the Board of Directors of the Company is scheduled on 24/11/2025 to consider and approve issuance of equity shares of the Company by way of a preferential issue for consideration other than cash.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1769.35
Dr. Reddys Labs. 1355.40
Cipla 1378.20
Lupin 2027.50
Zydus Lifesciences 1236.55
View more..